Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

The implementation of HTA in medicine pricing and reimbursement policies in Indonesia: Insights from multiple stakeholders.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
  • معلومة اضافية
    • المصدر:
      Publisher: Public Library of Science Country of Publication: United States NLM ID: 101285081 Publication Model: eCollection Cited Medium: Internet ISSN: 1932-6203 (Electronic) Linking ISSN: 19326203 NLM ISO Abbreviation: PLoS One Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: San Francisco, CA : Public Library of Science
    • الموضوع:
      Stakeholder Participation*; Health Plan Implementation/*standards ; Health Policy/*trends ; Prescription Drugs/*economics ; Reimbursement Mechanisms/*legislation & jurisprudence ; Technology Assessment, Biomedical/*organization & administration; Adult ; Female ; Humans ; Male ; Middle Aged ; Prescription Drugs/standards ; Qualitative Research ; Reimbursement Mechanisms/standards ; Universal Health Insurance
    • نبذة مختصرة :
      Objectives: This study aimed to identify the barriers and facilitators to improve the use of health technology assessment (HTA) for the selection of medicines listed in the e-Catalogue and the national formulary in Indonesia.
      Methods: Semi-structured interviews were conducted to collect qualitative data. Purposive sampling was used to recruit the stakeholders consisting of policymakers, a pharmaceutical industry representative, healthcare providers, and patients. The data were analyzed using directed content analysis and following the COnsolidated criteria for REporting Qualitative studies (COREQ).
      Results: The twenty-five participants interviewed agreed with the use of HTA for supporting the e-Catalogue and the national formulary and perceived the advantages of HTA implementation outweighed the disadvantages. Barriers mentioned were a lack of capability of local human resources, financial incentives, a clear framework and insufficient data. Strategies suggested to overcome the barriers were establishing (inter)national networks to build up capacity, setting up departments of HTA in several universities in Indonesia, and introducing a clear HTA framework. Facilitators mentioned were the ambition to achieve universal health coverage, the presence of legal frameworks to implement HTA in the e-Catalogue and the national formulary, and the demands for appropriate medicine policies.
      Conclusions: Several barriers are currently hampering broad implementation of HTA in medicine pricing and reimbursement policy in Indonesia. Solutions to these issues appear feasible and important facilitators exist.
      Competing Interests: The authors have declared that no competing interests exist.
    • References:
      Health Policy Plan. 2017 Oct 1;32(8):1102-1110. (PMID: 28575415)
      Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:241-52. (PMID: 19527543)
      PLoS One. 2019 Feb 19;14(2):e0212328. (PMID: 30779809)
      Value Health. 2012 Jan-Feb;15(1 Suppl):S126-31. (PMID: 22265059)
      Bull World Health Organ. 2017 Jul 1;95(7):537-539. (PMID: 28670019)
      Int J Qual Health Care. 2007 Dec;19(6):349-57. (PMID: 17872937)
      Lancet. 2013 Dec 21;382(9910):e48-9. (PMID: 24360390)
      J Pharm Policy Pract. 2015 Feb 16;8(1):8. (PMID: 25825675)
      Health Econ. 2016 Feb;25 Suppl 1:179-92. (PMID: 26763688)
      Qual Health Res. 2005 Nov;15(9):1277-88. (PMID: 16204405)
      Eur J Health Econ. 2018 Jan;19(1):123-152. (PMID: 28303438)
      Lancet. 2012 Jun 9;379(9832):2206-11. (PMID: 22682467)
    • الرقم المعرف:
      0 (Prescription Drugs)
    • الموضوع:
      Date Created: 20191128 Date Completed: 20200325 Latest Revision: 20200325
    • الموضوع:
      20221213
    • الرقم المعرف:
      PMC6881021
    • الرقم المعرف:
      10.1371/journal.pone.0225626
    • الرقم المعرف:
      31774854